Investment Review Report
트리메디칼
Business Reg. No. 3338701782 · CEO 문승열
I.Investment Overview
| Target | 트리메디칼 (3338701782) |
| Investment | — |
| Post-deal stake | — |
| Valuation | Pre — / Post — |
II.Investment Highlights
No investment highlights written yet.
III.Investment Risks
No risks written yet.
IV.Company Profile
| 회사명 | 트리메디칼 |
| 영문명 | Tree medical |
| 대표자 | 문승열 |
| 사업자등록번호 | 3338701782 |
| 법인등록번호 | 1358110383489 |
| 설립일 | 2020.01.17 |
| 종업원수 | 13명 |
V.Workforce
13
Current headcount · 2026.07 as of
VI.Financial Summary
Per DART disclosure · in 억/만원 (KRW)
Financial trend (100M KRW)
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| 자산총계 | 529.1억원 | 443.1억원 | 541.6억원 | 510억원 | 554.4억원 |
| 부채총계 | 455.4억원 | 367.6억원 | 457.1억원 | 430.4억원 | 467.8억원 |
| 자본총계 | 73.8억원 | 75.4억원 | 84.5억원 | 79.5억원 | 86.7억원 |
| 매출액 | 1,587.1억원 | 1,475.8억원 | 1,551.8억원 | 1,311.9억원 | 1,240.5억원 |
| 영업이익 | 99.4억원 | 96억원 | 109.1억원 | 96.1억원 | 103.3억원 |
| 순이익 | 65.1억원 | 62.8억원 | 75.8억원 | 69.1억원 | 75.6억원 |
VII.Financial Ratios
FY2025 basis
6.26%
영업이익률
4.1%
순이익률
12.3%
ROA
88.24%
ROE
617.21%
부채비율
13.94%
자기자본비율
VIII.Valuation & Exit Plan
| Exit valuation | — |
| Holding period | 5y |
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.
This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.